ACU Q2 2026 Earnings: EPS Surges 50% on MyMedic Acquisition and Margin Expansion

• Acme United reported Q2 2026 EPS of $1.22, significantly beating consensus estimates by 50.62%.
• Revenue reached $62.7 million, surpassing forecasts of $58.1 million and reflecting a 16% year-over-year sales increase.
• Gross margins expanded to 42.6% from 41.0% in the prior year, driven by easing tariff pressures and inventory transitions .
• The stock surged approximately 11.92% following the report, moving near its 52-week high of $51.88 .

Acme United Corporation delivered a robust second-quarter 2026 performance, significantly outperforming Wall Street expectations across both earnings and revenue metrics. The company reported earnings per share of $1.22, a substantial beat against the consensus forecast of $0.81 . This 50.62% surprise underscores the effectiveness of recent strategic initiatives, particularly the integration of the MyMedic acquisition .

Revenue came in at $62.7 million, exceeding analyst projections of $58.1 million by nearly 8% . The top-line growth was primarily fueled by a 16% year-over-year increase in sales . While the MyMedic acquisition contributed significantly to this expansion, organic growth stood at a solid 8%, indicating strong underlying business momentum .

A key operational highlight was the improvement in profitability metrics. Gross margins expanded to 42.6%, up from 41.0% in the same period last year . Management attributed this margin recovery to the strategic replacement of higher-tariff inventory with lower-cost stock . CEO Johnsen indicated that this trend is expected to continue as tariff pressures ease throughout the remainder of the year .

How Did MyMedic Drive Growth?

The acquisition of MyMedic has become a central pillar of Acme United’s growth strategy. The integration is progressing well, with the company shifting its strategic focus from direct-to-consumer channels toward mass retail expansion . This transition aims to broaden distribution networks and capture larger market share in the medical safety segment .

The MyMedic contribution helped drive the 16% year-over-year sales increase, demonstrating the value of the acquisition in boosting top-line performance . However, investors should note that a portion of this growth is attributed to the acquisition rather than purely organic expansion . Despite this, the 8% organic growth rate suggests that the core business remains resilient and capable of independent expansion .

Management anticipates that the integration will yield further benefits in the coming quarters. The focus on mass retail channels is expected to provide more stable and scalable revenue streams compared to direct-to-consumer models . This strategic pivot aligns with broader industry trends toward consolidated distribution in the medical safety sector .

What Are the Key Risks to Monitor?

Despite the strong quarterly results, several risks warrant investor attention. Selling, general, and administrative (SG&A) expenses remain elevated at 32% of sales, potentially pressuring net income . These high operational costs could limit the full realization of margin improvements in the short term .

External factors also pose challenges. Potential fluctuations in tariff and freight costs could impact profitability if supply chain dynamics shift unfavorably . Additionally, currency volatility presents a headwind, particularly for international operations . Geographic performance has been uneven, with Canadian operations lagging behind other regions .

Looking ahead, the company anticipates strong fourth-quarter profitability driven by seasonal demand patterns . However, the combination of elevated SG&A expenses and external economic pressures requires careful monitoring . Investors should weigh the strong earnings beat against these ongoing operational and macroeconomic risks .

The market responded positively to the earnings release, with shares surging nearly 12% to approach their 52-week high of $51.88 . This price action reflects investor confidence in the company’s ability to navigate tariff challenges and successfully integrate new acquisitions .

Acme United’s performance highlights the importance of strategic acquisitions in driving growth, even in a complex macroeconomic environment . The company’s focus on margin expansion and operational efficiency remains a key theme for future quarters .